Your browser doesn't support javascript.
loading
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.
Gupta, Samir; Provenzale, Dawn; Llor, Xavier; Halverson, Amy L; Grady, William; Chung, Daniel C; Haraldsdottir, Sigurdis; Markowitz, Arnold J; Slavin, Thomas P; Hampel, Heather; Ness, Reid M; Weiss, Jennifer M; Ahnen, Dennis J; Chen, Lee-May; Cooper, Gregory; Early, Dayna S; Giardiello, Francis M; Hall, Michael J; Hamilton, Stanley R; Kanth, Priyanka; Klapman, Jason B; Lazenby, Audrey J; Lynch, Patrick M; Mayer, Robert J; Mikkelson, June; Peter, Shajan; Regenbogen, Scott E; Dwyer, Mary A; Ogba, Ndiya.
Afiliação
  • Gupta S; UC San Diego Moores Cancer Center.
  • Provenzale D; Duke Cancer Institute.
  • Llor X; Yale Cancer Center/Smilow Cancer Hospital.
  • Halverson AL; Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Grady W; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.
  • Chung DC; Massachusetts General Hospital Cancer Center.
  • Haraldsdottir S; Stanford Cancer Institute.
  • Markowitz AJ; Memorial Sloan Kettering Cancer Center.
  • Slavin TP; City of Hope National Medical Center.
  • Ness RM; Vanderbilt-Ingram Cancer Center.
  • Weiss JM; University of Wisconsin Carbone Cancer Center.
  • Ahnen DJ; University of Colorado Cancer Center.
  • Chen LM; UCSF Helen Diller Family Comprehensive Cancer Center.
  • Cooper G; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.
  • Early DS; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.
  • Giardiello FM; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.
  • Hall MJ; Fox Chase Cancer Center.
  • Hamilton SR; The University of Texas MD Anderson Cancer Center.
  • Kanth P; Huntsman Cancer Institute at the University of Utah.
  • Klapman JB; Moffitt Cancer Center.
  • Lazenby AJ; Fred & Pamela Buffett Cancer Center.
  • Lynch PM; The University of Texas MD Anderson Cancer Center.
  • Mayer RJ; Dana-Farber/Brigham and Women's Cancer Center.
  • Peter S; O'Neal Comprehensive Cancer Center at UAB.
  • Regenbogen SE; University of Michigan Rogel Cancer Center; and.
  • Ogba N; National Comprehensive Cancer Network.
J Natl Compr Canc Netw ; 17(9): 1032-1041, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31487681
Identifying individuals with hereditary syndromes allows for improved cancer surveillance, risk reduction, and optimized management. Establishing criteria for assessment allows for the identification of individuals who are carriers of pathogenic genetic variants. The NCCN Guidelines for Genetic/Familial High-Risk Assessment: Colorectal provide recommendations for the assessment and management of patients with high-risk colorectal cancer syndromes. These NCCN Guidelines Insights focus on criteria for the evaluation of Lynch syndrome and considerations for use of multigene testing in the assessment of hereditary colorectal cancer syndromes.
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Predisposição Genética para Doença / Estudos de Associação Genética Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Predisposição Genética para Doença / Estudos de Associação Genética Tipo de estudo: Diagnostic_studies / Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Natl Compr Canc Netw Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article